Drugs that affect noradrenaline release

DRUGS THAT AFFECT NORADRENALINE RELEASE

  • The mechanisms by which these drugs interfere with release of noradrenaline include:
    • inhibition of noradrenaline release in response to depolarization of the nerve terminal and/or
    • complete depletion of noradrenaline from its storage sites.  

Guanethidine

  • It is selectively inhibits release of noradrenaline from peripheral postganglionic adrenergic neurons, with no effect on adrenal medulla.
  • Mechanism of action
    • Guanethidine has complex mechanism of action.
    • It has bretylium like effect-blocks nerve impulse coupled release of stored noradrenaline
    • Tyramine like effect-displaces noradrenaline from storage vesicles
    • Reserpine like effect-causes gradual depletion of noradrenaline in storage vesicles
    • Blocks uptake1 carrier transport system for noradrenaline
    • When chronically administered guanethidine acts as a “substitute neurotransmitter”, as it is stored noradrenaline storage vesicles and is released by stimuli that normally release noradrenaline.
    • Has some local anesthetic like action
    • Guanethidine in large doses caused structural damage to adrenergic neurons.
  • Pharmacological effects
    • Following oral administration, guanethidine produces fall in blood pressure and bradycardia, because of decreased release of noradrenaline. However, after IV administration, it produces characteristic triphasic response in blood pressure.
    • Initially it produces decrease in blood pressure (due to decreased peripheral resistance an cardiac output, resulting from initial noradrenaline blockade).
    • The fall is then followed by increase in blood pressure (due to release of noradrealine) and then finally there is fall in blood pressure ( due to depletion of noradrenaline).
  • Clinical uses: Seldom used in veterinary practice.

Bretylium

  • Inhibits the release of noradrenaline, accumulates in nerve terminals and exerts a selective local anesthetic effect on sympathetic nerve terminals.
  • It does not block release of catecholamines from adrenal medulla and does not affect nerve terminals other than those that release nor adrenaline.
  • Bretylium also has effect on K+ channels in myocardium and exerts anti arrhythmic effect.
Last modified: Monday, 17 October 2011, 7:12 AM